ANDRES BAEZA: Open Payments
NPI 1003454174 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,173 in 72 payments from 10 companies in 2025. Trend: 2023 $1,955 · 2024 $2,143 · 2025 $2,173
Food & beverage: $2,061Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 5 | $324 |
| Janssen Pharmaceuticals, Inc | 5 | $312 |
| E.R. Squibb & Sons, L.L.C. | 8 | $306 |
| Neurocrine BioSciences, Inc. | 12 | $261 |
| Otsuka America Pharmaceutical, Inc. | 9 | $217 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $182 |
| Alkermes, Inc. | 7 | $175 |
| ABBVIE INC. | 9 | $146 |
| Lundbeck LLC | 8 | $139 |
| Axsome Therapeutics, Inc. | 5 | $111 |
Products named: COBENFY, INGREZZA, REXULTI, CAPLYTA, SPRAVATO, VRAYLAR, INVEGA SUSTENNA, AUSTEDO XR.
Industry payments across TX — which companies pay providers there.
